Indian scientists flag coronavirus mutations that could ‘evade immune response’

Published May 2, 2021
People get their names registered after receiving a dose of Covishield, a Covid-19 vaccine manufactured by Serum Institute of India, at a vaccination centre in Ahmedabad, India, May 1. — Reuters
People get their names registered after receiving a dose of Covishield, a Covid-19 vaccine manufactured by Serum Institute of India, at a vaccination centre in Ahmedabad, India, May 1. — Reuters

A forum of scientific advisers set up by the Indian government has told authorities about minor mutations in some samples of the coronavirus that could “possibly evade immune response” and require more study, a leader of the forum has told Reuters.

However, the advisers said while they were flagging the mutations, there was no reason currently to believe they were expanding or could be dangerous.

Scientists are studying what led to the current surge in cases in India and particularly whether a variant first detected in the country, called B.1.617, is to blame. The World Health Organisation (WHO) has not declared the Indian variant a “variant of concern,” as it has done for variants first detected in Britain, Brazil and South Africa. But the WHO said on April 27 that its early modelling, based on genome sequencing, suggested that B.1.617 had a higher growth rate than other variants circulating in India.

The forum of advisers, known as the Indian SARS-CoV-2 Genetics Consortium, or INSACOG, has now found more mutations in the coronavirus that it thinks need to be tracked closely.

"We are seeing some mutation coming up in some samples that could possibly evade immune responses," said Shahid Jameel, chair of the scientific advisory group of INSACOG and a top Indian virologist. He did not say if the mutations have been seen in the Indian variant or any other strain.

"Unless you culture those viruses and test them in the lab, you can't say for sure. At this point, there is no reason to believe that they are expanding or if they can be dangerous, but we flagged it so that we keep our eye on the ball," he said.

INSACOG brings together 10 national research laboratories.

India reported more than 400,000 new Covid-19 cases for the first time on Saturday. The rampaging infections have collapsed its health system in places including capital New Delhi, with shortages of medical oxygen and hospital beds.

Opinion

ECP roars back
19 Jun 2021

ECP roars back

The bill is a shocking manifestation of the PTI government’s unilateral push to have its way...
Meeting at the top
19 Jun 2021

Meeting at the top

There must be the will to listen, to confer and to compromise...
Budgeting with constraints
Updated 18 Jun 2021

Budgeting with constraints

The budget strategy will deliver growth but raises the risk of external account stress.

Editorial

19 Jun 2021

NA peace — for now

AFTER a session of utter pandemonium and a distasteful war of words, normalcy finally returned to the National...
19 Jun 2021

India uranium theft

REPORTS emerging from India about the theft of uranium and possible sale on the black market should be a cause for...
19 Jun 2021

KCR rigmarole

THURSDAY’S proceedings in the Supreme Court clearly demonstrated how divided the stakeholders are when it comes to...
Poll bill reservations
Updated 18 Jun 2021

Poll bill reservations

Reforming the electoral process is vital for Pakistan, and doing so by taking everyone on board is equally important.
18 Jun 2021

E-fund transfer fee

THE State Bank’s decision to withdraw the facility of free of cost digital fund transfer services is disappointing...
18 Jun 2021

Gaza bombed again

MEMORIES of last month’s savage assault by Israel targeting Gaza had not yet faded when earlier this week news...